Viw Magazine

The Times


.

AIM Vaccine’s heavyweight single-product mRNA RSV Vaccine obtained the clinical trial approval

HONG KONG SAR - Media OutReach Newswire - 30 October 2024 - AIM Vaccine (06660.HK), the leader in Chinese mRNA vaccines, announced on 30th October that mRNA respiratory syncytial virus (RSV) vaccine developed by a controlled subsidiary of the Group , has been recently obtained from the National Medical Products Administration, which marks a new progress of the research and development of the vaccine.

Read more …

LifeStyle

What to Add to Your Weekly Diet for Stronger, Glossier Strands

Achieving thick, vibrant hair requires more than just high-quality shampoos and topical serums. Real...

How to Reverse Sun Damage and Restore Moisture to Your Hair

Australia's harsh summer sun takes a heavy toll on our tresses, leaving them dry, brittle, and pro...

How to Build a Daily Hair Care Routine for Stronger, Shinier Strands

Achieving lustrous, resilient hair requires consistent daily care rather than occasional expensive...

What to Do for Fine Hair to Instantly Boost Volume

Fine, flat hair often feels like a daily styling challenge, leaving many searching for ways to injec...